The impact of active HIV-1 replication on the physiological age-related decline of immature-transitional B-cells in HIV-1 infected children

AIDS

Volumn 24, Issue 13, 2010, Pages 2075-2080

  Cagigi, Alberto ^a   Palma, Paolo ^b,c   Nilsson, Anna ^c,e   Di Cesare, Silvia ^c   Pensieroso, Simone ^d   Kakoulidou, Maria ^f   Bernardi, Stefania ^c   Rossi, Paolo ^b,c   Chiodi, Francesca ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d Tumor and Cell Biology   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

BAFF; CXCL12; CXCR4; interleukin 7; pediatric AIDS

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; B CELL ACTIVATING FACTOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; INTERLEUKIN 7;

ADOLESCENT; ARTICLE; CELL LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LYMPHOCYTE HOMING; MEMORY CELL; PERIPHERAL LYMPHOCYTE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD; VERTICAL TRANSMISSION; VIREMIA; VIRUS REPLICATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PRECURSOR CELLS, B-LYMPHOID; RECEPTORS, CXCR4; VIREMIA;

EID: 77955431162     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833c3298     Document Type: Article

References (20)

1. Capolunghi F, Cascioli S, Giorda E, Rosado MM, Plebani A, Auriti C, et al. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 2008; 180:800-808.
2. Jacobsen MC, Thiebaut R, Fisher C, Sefe D, Clapson M, Klein N, Baxendale HE. Pediatric human immunodeficiency virus infection and circulating IgDR memory B cells. J Infect Dis 2008; 198:481-485.
3. Pensieroso S, Cagigi A, Palma P, Nilsson A, Capponi C, Freda E, et al. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci\USA 2009; 106:7939-7944.
4. Malaspina A, Moir S, Ho J, Wang W, Howell ML, O'Shea MA, et al. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci\USA 2006; 103:2262-2267.
5. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111:77-85.
6. Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome. J Immunol 2001; 167:3610-3618.
7. Agematsu K, Hokibara S, Nagumo H, Komiyama A. CD27: a memory B-cell marker. Immunol Today 2000; 21:204-206.
8. Anolik JH, Barnard J, Owen T, Zheng B, Kemshetti S, Looney RJ, Sanz I. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum 2007; 56:3044-3056.
9. Okada T, Cyster JG. B cell migration and interactions in the early phase of antibody responses. Curr Opin Immunol 2006; 18:278-285.
10. Moir S, Malaspina A, Ho J, Wang W, Dipoto AC, O'Shea MA, et al. Normalization of B Cell Counts and Subpopulations after Antiretroviral Therapy in Chronic HIV Disease. J Infect Dis 2008; 197:572-579.
11. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009; 9:235-245.
12. Cagigi A, Mowafi F, Phuong Dang LV, Tenner-Racz K, Atlas A, Grutzmeier S, et al. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood 2008; 112:4401-4410.
13. Muehlinghaus G, Cigliano L, Huehn S, Peddinghaus A, Leyen-deckers H, Hauser AE, et al. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 2005; 105:3965-3971.
14. Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N, et al. Chemokine receptor CXCR4-dependent internaliza-tion and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 2005; 6:1038-1046.
15. Qin S, Sui Y, Murphey-Corb MA, Reinhart TA. Association between decreased CXCL12 and CCL25 expression and increased apoptosis in lymphoid tissues of cynomolgus macaques during SIV infection. J Med Primatol 2008; 37 (Suppl 2):46-54.
16. Jin CZ, Zhao Y, Zhang FJ, Yao HP, Wu LJ, Zhao HX, et al. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China. Chin Med J (Engl) 2009; 122:530-535.
17. Meyer-Bahlburg A, Andrews SF, Yu KO, Porcelli SA, Rawlings DJ. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J Exp Med 2008; 205:155-168.
18. Parrish YK, Baez I, Milford TA, Benitez A, Galloway N, Rogerio JW, et al. IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow. J Immunol 2009; 182:4255-4266.
19. Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 2007; 7:144-154.
20. Boulassel MR, Samson J, Khammy A, Lapointe N, Soudeyns H, Routy JP. Predictive value of interleukin-7 levels for virological response to treatment in HIV-1-infected children. Viral Immunol 2007; 20:649-656.